A large meta-analysis of over 20,000 people found that modern genetic testing can identify a clinically meaningful cause of schizoprenia in about 1 in 16 patients (6%), especially in early-onset ...

Genomics improves healthcare and prevention of all major diseases by early personalized insight into health, and Europe needs ...

The whole-exome sequencing (WES) significantly improves diagnostic accuracy for monogenic foetal structural anomalies (FSAs), ...

Good day, and welcome to the Bionano Fourth Quarter and Full Year 2025 Earnings Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Webb ...

OGM VIA customers represent a meaningful software revenue stream and a natural on-ramp to broader Bionano Genomics, Inc. adoption at these customer sites. The IONIQ system continues to expand, ...

The global digital dentistry market is growing steadily, expected to be valued at around US$ 7.2 billion in 2026 and ...

Bionano Genomics, Inc. (NASDAQ:BNGO) Q4 2025 Earnings Call Transcript March 23, 2026 Bionano Genomics, Inc. reports earnings ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.

Background Chromosome 19 is the most gene-dense chromosome in the human genome, with a high frequency of segmental ...

Two decades of cloning experiments in mice have produced a striking pattern: animals created through somatic cell nuclear ...